A Step-By-Step Guide for Determining the Eligibility of Your Organization and Initiating 340B Contracts.
Section 340B Contract Creation & Management Section 340B of the Public Service Act makes it possible for Disproportionate Share Hospitals (DSH) and other healthcare‐related entities to serve underprivileged populations more cost‐effectively. Section
340B requires drug manufacturers provide outpatient medications at lower prices to eligible healthcare organizations, or “Covered Entities.” A 340B contract can provide tremendous savings to a covered entity, and initiating the contract is a relatively straightforward process which can be completed in a few short steps.
View the Full article online at Establishing 340B Eligibility
Tuesday, September 8, 2009
TALYST PARTNERS WITH WELLFOUNT PHARMACY TO ELIMINATE MEDICATION WASTE IN LONG-TERM CARE
Talyst InSite™, the first pharmacy automation system designed specifically for long-term care facilities, enables on-demand dispensing, greatly reducing medication waste and nursing time.
Talyst announced today its new partnership with Wellfount Pharmacy, an Indianapolis-based pharmacy that services long-term care facilities. Wellfount will implement Talyst’s InSiteRX Remote Dispensing System in long-term care facilities to increase efficiency and reduce medication waste and errors. Talyst made the announcement today at the American Society of Consultant Pharmacists (ASCP) Midyear Meeting in Orlando, Florida.
“We looked at other dispensing solutions but Talyst was the only player that really understood the long-term care market,” said Paul Leamon, president and CEO of Wellfount. “The complexities and regulations within the long-term care make it ripe for automation. We’re working with Talyst to provide the technology that will save nurses time, make patients safer, and decrease medication waste — positively impacting both the environment and the bottom line.”
Traditionally, Wellfount would deliver medication inventory to long-term care facilities in 14- or 28-day supplies, creating medication waste whenever a patient’s prescription changed, or the patient transferred facilities or passed away. Furthermore, according to Leamon, the patients Wellfount services take an average 12 prescriptions a day. With different doctors, pharmacists, administrators and nurses involved in each individual prescription, yet not always in direct contact with one another, the potential for error was always a top concern.
With the InSite Remote Dispensing System, Talyst places a freestanding, secure dispensing unit on site at the long-term care facility. When it is time for a patient to receive their medications, the InSite unit dispenses patient-specific multi-dose packets, each printed with the patient’s name, the name of the medication, and a verifying bar code. The nurse scans the bar code with a handheld scanner, verifies the patient and medication information, and administers the medications. Because the prescriptions are dispensed on-demand, there is practically no opportunity for medication waste or error.
Medication orders can be approved by a distant pharmacist and immediately dispensed at the long-term care facility. The automated system means prescription changes or STAT orders are not delayed by delivery times. The facility also requires less medication inventory on-hand because inventory is determined by actual usage.
See the full article at Talyst Eliminates Medication Waste
Talyst announced today its new partnership with Wellfount Pharmacy, an Indianapolis-based pharmacy that services long-term care facilities. Wellfount will implement Talyst’s InSiteRX Remote Dispensing System in long-term care facilities to increase efficiency and reduce medication waste and errors. Talyst made the announcement today at the American Society of Consultant Pharmacists (ASCP) Midyear Meeting in Orlando, Florida.
“We looked at other dispensing solutions but Talyst was the only player that really understood the long-term care market,” said Paul Leamon, president and CEO of Wellfount. “The complexities and regulations within the long-term care make it ripe for automation. We’re working with Talyst to provide the technology that will save nurses time, make patients safer, and decrease medication waste — positively impacting both the environment and the bottom line.”
Traditionally, Wellfount would deliver medication inventory to long-term care facilities in 14- or 28-day supplies, creating medication waste whenever a patient’s prescription changed, or the patient transferred facilities or passed away. Furthermore, according to Leamon, the patients Wellfount services take an average 12 prescriptions a day. With different doctors, pharmacists, administrators and nurses involved in each individual prescription, yet not always in direct contact with one another, the potential for error was always a top concern.
With the InSite Remote Dispensing System, Talyst places a freestanding, secure dispensing unit on site at the long-term care facility. When it is time for a patient to receive their medications, the InSite unit dispenses patient-specific multi-dose packets, each printed with the patient’s name, the name of the medication, and a verifying bar code. The nurse scans the bar code with a handheld scanner, verifies the patient and medication information, and administers the medications. Because the prescriptions are dispensed on-demand, there is practically no opportunity for medication waste or error.
Medication orders can be approved by a distant pharmacist and immediately dispensed at the long-term care facility. The automated system means prescription changes or STAT orders are not delayed by delivery times. The facility also requires less medication inventory on-hand because inventory is determined by actual usage.
See the full article at Talyst Eliminates Medication Waste
Subscribe to:
Posts (Atom)
Posts
